- Home
- GNSS vs ANVS Comparison
GNSS vs ANVS Comparison
Compare GNSS & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNSS
- ANVS
- Stock Information
- Founded
- GNSS 1992
- ANVS 2008
- Country
- GNSS United States
- ANVS United States
- Employees
- GNSS N/A
- ANVS N/A
- Industry
- GNSS Consumer Electronics/Appliances
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- GNSS Consumer Staples
- ANVS Health Care
- Exchange
- GNSS Nasdaq
- ANVS Nasdaq
- Market Cap
- GNSS 169.5M
- ANVS 110.4M
- IPO Year
- GNSS N/A
- ANVS 2020
- Fundamental
- Price
- GNSS $3.75
- ANVS $9.64
- Analyst Decision
- GNSS Strong Buy
- ANVS Strong Buy
- Analyst Count
- GNSS 3
- ANVS 6
- Target Price
- GNSS $5.08
- ANVS $29.67
- AVG Volume (30 Days)
- GNSS 106.7K
- ANVS 341.4K
- Earning Date
- GNSS 12-05-2024
- ANVS 11-06-2024
- Dividend Yield
- GNSS N/A
- ANVS N/A
- EPS Growth
- GNSS N/A
- ANVS N/A
- EPS
- GNSS N/A
- ANVS N/A
- Revenue
- GNSS $27,968,000.00
- ANVS N/A
- Revenue This Year
- GNSS N/A
- ANVS N/A
- Revenue Next Year
- GNSS $138.10
- ANVS N/A
- P/E Ratio
- GNSS N/A
- ANVS N/A
- Revenue Growth
- GNSS N/A
- ANVS N/A
- 52 Week Low
- GNSS $1.51
- ANVS $4.53
- 52 Week High
- GNSS $4.04
- ANVS $22.49
- Technical
- Relative Strength Index (RSI)
- GNSS 60.29
- ANVS 58.70
- Support Level
- GNSS $3.67
- ANVS $9.00
- Resistance Level
- GNSS $3.94
- ANVS $10.54
- Average True Range (ATR)
- GNSS 0.14
- ANVS 0.81
- MACD
- GNSS -0.02
- ANVS 0.12
- Stochastic Oscillator
- GNSS 77.78
- ANVS 74.57
About GNSS Genasys Inc.
Genasys Inc is a provider of critical communications solutions designed to help keep people safe. The company is engaged in the design, development, and commercialization of directed and multidirectional sound technologies, voice broadcast products and location-based mass messaging solutions for emergency warning and workforce management. Its operating segment includes Hardware and Software. The company generates maximum revenue from the Hardware segment. Geographically, it derives a majority of revenue from the Americas region and also has its presence in the Asia Pacific and Europe, Middle East and Africa.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.